Researchers offer new and additional evidence that a naturally occurring compound may be a valuable treatment for pulmonary hypertension. The…
Articles by Magdalena Kegel
United Therapeutics and Corsair Pharma are teaming up to advance Corsair’s development of a blood-vessel-widening skin patch for treating…
Scleroderma patients with newly diagnosed pulmonary arterial hypertension (PAH) have significantly higher healthcare costs than those without PAH, a Colorado…
Beginning in January 2018, people with pulmonary hypertension (PH) and their caregivers can apply for stipends to attend next year’s …
Development work on INOpulse as a treatment for pulmonary hypertension is advancing in all three patient groups, Bellerophon Therapeutics announced…
Actelion’s Opsumit (macitentan) made it easier for blood to pass through the lung blood vessels of chronic thromboembolic pulmonary…
A University of Oregon researcher played a key role in the early work that led to Complexa’s pulmonary hypertension…
Diethylcarbamazine, a compound used to fight a tropical parasitic disease, might effectively treat pulmonary hypertension (PH), a Brazilian research team…
The female sex hormone estrogen may prevent disease progression of pulmonary hypertension — at least if results in rats can be…
Three ongoing clinical trials are recruiting additional participants to allow for more robust assessments of Reata…
Arena Pharmaceuticals will present new information in Barcelona this weekend on its pulmonary hypertension therapy ralinepag, which a clinical trial…
The exercise capacity of people with scleroderma who have yet to develop pulmonary arterial hypertension (PAH) diminishes over time, according…